Back

Prevalence and prognostic impact of cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. AMY-TAVI study.

27 August 2022 (15:50 - 16:00)
Organised by:
Congress Presentation Part of: Transcatheter aortic valve implantation: trends, outcomes, and procedural considerations Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Diego Lopez Otero

University Hospital of Santiago de Compostela, Santiago de Compostela (Spain)

5 More presentations in this session

Presentation thumbnail
Trends in outcomes, complications and readmission rates in patients undergoing transcatheter aortic valve implantation: a nationwide analysis from 2012 to 2019
Doctor A. Goel (Valhalla, US)
Abstract Slides Video
Presentation thumbnail
Hospital procedural volume and clinical outcomes for transcatheter aortic valve replacement - US nationwide readmission database, 2016-2019.
Doctor O. Al-Taweel (Las Vegas, US)
Abstract Slides Video
Presentation thumbnail
Impact of periprocedural pulmonary hypertension on outcomes after TAVR: novel risk stratification from the OCEAN-TAVI Registry
Doctor J. Miyamoto (Kanagawa, JP)
Abstract Slides Video
Presentation thumbnail
Bioprosthetic valve fracture during valve-in-valve transcatheter aortic valve replacement: multicenter propensity matched analysis
Doctor G. Bonnet (Bordeaux, FR)
Abstract Slides Video
Presentation thumbnail
Comparison of the safety and efficacy of antithrombotic regimens following TAVR in patients without having an indication for chronic oral anticoagulation
Doctor P. Guedeney (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Transcatheter aortic valve implantation: trends, outcomes, and procedural considerations

The Event

Event poster

ESC Congress 2022

27 August 2022 15:50 CET
You may be interested in
thumbnail
Congress Presentation
Evolving the understanding of TTR's role in health and disease​
thumbnail
Congress Presentation
Exploring ATTR cardiomyopathy: the journey to improved outcomes
thumbnail
Congress Presentation
Exploring the wealth of long-term data for ATTR-CM management​

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources